Institutional Biosafety Committee (IBC) Meeting Minutes
Research Transparency & NIH Compliance
Research Network Arizona is committed to transparency and compliance with applicable research guidelines.
This page provides public access to Institutional Biosafety Committee (IBC) meeting minutes and related research documentation.
The National Institutes of Health (NIH) Office of Science Policy requires IBC meeting minutes to be made publicly available on the institution’s own website. Minutes are posted here following each IBC review meeting, after any allowable redactions have been made.

Available Research Documents
Documents are grouped by study, with the most recent meeting listed first. Select a document to open it as a PDF.
What Is an Institutional Biosafety Committee?
An Institutional Biosafety Committee (IBC) reviews research that involves recombinant or synthetic nucleic acid molecules, such as gene therapy studies, to make sure the work is carried out safely for participants, staff, and the community.
Under the NIH Guidelines, an IBC has at least five members, including at least two members who are not affiliated with the institution and who represent the interests of the surrounding community.
The committee’s review of a study typically covers:


